Introduction {#sec1-2045894020912937}
============

Group 3 pulmonary hypertension (PH) is classified as PH developing as a result of chronic lung diseases (CLDs).^[@bibr1-2045894020912937][@bibr2-2045894020912937]--[@bibr3-2045894020912937]^ CLDs are debilitating pathologies that impede overall tissue function, and as such, are a leading cause of mortality. Vasculopathy is a frequent comorbidity in CLD and may be characterized by deregulated or adaptive angiogenesis, remodeling, and loss of microvessels. Such remodeling may result in the development of PH, which significantly worsens prognosis and outcome.^[@bibr4-2045894020912937]^ PH is observed in many CLDs, including pulmonary fibrosis, chronic obstructive pulmonary disease (COPD)/emphysema, interstitial lung disease associated with systemic sclerosis as well as lymphangioleiomyomatosis.^[@bibr1-2045894020912937],[@bibr5-2045894020912937][@bibr6-2045894020912937][@bibr7-2045894020912937][@bibr8-2045894020912937][@bibr9-2045894020912937][@bibr10-2045894020912937][@bibr11-2045894020912937][@bibr12-2045894020912937]--[@bibr13-2045894020912937]^

Although the underlying pathogenesis of vascular remodeling and dysfunction in COPD or fibrosis remains unclear, it is increasingly evident that they develop in the early stages of fibrosis,^[@bibr8-2045894020912937],[@bibr10-2045894020912937],[@bibr14-2045894020912937][@bibr15-2045894020912937][@bibr16-2045894020912937][@bibr17-2045894020912937][@bibr18-2045894020912937][@bibr19-2045894020912937][@bibr20-2045894020912937][@bibr21-2045894020912937][@bibr22-2045894020912937][@bibr23-2045894020912937][@bibr24-2045894020912937]--[@bibr25-2045894020912937]^ as well as COPD.^[@bibr26-2045894020912937][@bibr27-2045894020912937][@bibr28-2045894020912937][@bibr29-2045894020912937][@bibr30-2045894020912937]--[@bibr31-2045894020912937]^ More recently, type 2 immunity is thought to play a significant role in muscularization of the pulmonary vasculature.^[@bibr32-2045894020912937][@bibr33-2045894020912937][@bibr34-2045894020912937][@bibr35-2045894020912937]--[@bibr36-2045894020912937]^ Furthermore, despite advances in understanding some of the effects of pulmonary vascular remodeling to the development of emphysema, its effect on the phenotypic manifestations and severity of epithelial remodeling in CLD remain unknown. These gaps in knowledge underscore the need for future mechanistic investigations of the crosstalk between the vasculature and airways in CLD.

Typically, studies are performed separately to analyze either the cardiovascular hemodynamics or the airway physiology. Taken together, the literature supports that there is an inability to sustain functional tissue repair in both the vascular and epithelial compartments during disease. Therefore, we must begin to understand and model the underlying pathophysiology of pulmonary vascular deregulation, both alone and in combination with airway physiology in response to injury-induced disease.

These studies were designed to test the hypothesis that complementary airway physiology and cardiovascular hemodynamic analyses could be performed in tandem, on a single animal, to elucidate the interactions between the compartments necessary to maintain normal pulmonary tissue function and promote repair. Here, we provide a detailed protocol for the analysis of airway physiology with subsequent cardiovascular hemodynamics in a single mouse. Combining the use of these technologies increases the number of relevant endpoints that may be collected and potential numbers per group. These data collected in parallel will greatly enhance the understanding of two vital components of lung tissue, the vasculature and airways. These combined analyses will also enhance our understanding of the progression of vascular dysfunction in parallel to the development of CLD.

Methods {#sec2-2045894020912937}
=======

Study approval {#sec3-2045894020912937}
--------------

The Institutional Animal Care and Use Committee at National Jewish Health approved all animal procedures and protocols. C57Bl6J mice were purchased from Jackson labs at 16 weeks of age and allowed to acclimate to Denver\'s altitude (∼5280 ft) for 2.5 weeks. \[Both 'flexivent' and 'flexiVent' are used. Please consider following consistency.\]To validate the flexivent with hemodynamics measurements, mice were randomized into groups for a total of 7--9 animals per group. The groups included hemodynamics only (Hdx), flexivent only (Flexi), and flexivent + Hdx (Flexi + Hdx) ([Table 1](#table1-2045894020912937){ref-type="table"}). For long-term studies, age matched mice were induced with low-dose tamoxifen (0.5 mg/18 g mouse) and housed for one year.^[@bibr37-2045894020912937]^ The groups included 10 wild type (WT 5 male and 5 female) and Wingless-related integration site (Wnt) activated mice (Bcatenin overexpression (BOE) 5 male (4 died) and 5 female, 1 died). Table 1.Pulmonary physiology measures per mouse.GroupSexWeight (g)HCTRV/ LV + SRVSP (mmHg)LVSP (mmHg)CO (mL/ min)HR (beats/min)Mean systemic pressure (mmHg)PA pressure (mmHg)Rrs (cmH~2~O.s/ mL)Crs (mL/ cmH~2~O)Ers (cmH~2~O/ mL)Rn (cmH~2~O.s/ mL)Cst (mL/ cmH~2~O)HdxF21.8360.2024.179.66710.2867852.4814.26HdxF20.9480.2328.61594.68310.0962729.92HdxF20.1380.2320.23341.7238.3552627.0112.64HdxM28.50.1829.70677.80514.3868249.5930.94HdxM30.3460.1923.6103.5156.4967085.4134.84HdxM29.4460.2128.43675.95710.9967673.624.91HdxM29370.2327.91450.63711.857532.43FlexiF21.70.19540^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.4210.044422.5260.1990.075FlexiF20490.21576^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5710.03826.3830.2900.067FlexiF21.1530.18525^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.6330.03627.5840.3390.059FlexiM31.8460.17579^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5760.03727.1370.2510.065FlexiM30.2480.22450^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5240.04820.7420.3180.071FlexiM28.7400.20350^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5090.05020.0310.2830.079FlexiF18.9460.18550^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5820.03528.2960.1700.058FlexiF17.6420.24525^[a](#table-fn1-2045894020912937){ref-type="table-fn"}^0.5550.03826.5530.2080.067Flexi + HdxM28.6470.2626.21177.7769.2664848.3131.610.6430.03528.3160.3290.063Flexi + HdxF21.9430.2625.43945.7847.9256324.0324.210.8080.02836.2720.2670.052Flexi + HdxF21.2400.2524.44481.0412.6961043.0720.530.5360.03926.0150.2030.070Flexi + HdxF20.5410.2030.75145.9347.4457430.260.5440.04124.6930.2440.069Flexi + HdxF21.3460.2022.19968.9978.1763050.7312.840.5350.04323.2940.3400.069Flexi + HdxM29480.2027.24678.4518.9857655.6325.831.0340.052419.1050.2930.079Flexi + HdxM30.3450.2224.47108.1139.6763873.6817.20.4360.04820.8770.2160.073Flexi + HdxM27.7440.2128.64776.46310.863258.9829.680.3920.05518.2550.2130.087Flexi + HdxM31.7430.2420.28538.57310.715982719.310.4720.04621.6030.2530.076[^2]

Surgical manipulation {#sec4-2045894020912937}
---------------------

Animals were induced with 4--5% isoflurane in room air at 1 L/min for approximately 2 min. The animal was then removed and placed in the supine position for passive ventilation via nosecone. The ventral neck and torso were shaved, and an incision was made down the midline of the neck, and tissue was blunt dissected to expose the trachea. A 1--2 mm incision was made in the trachea and a mouse endotracheal tube (Hallowell EMC, 201A3353) or 18 G metal cannula placed into the trachea with 4-0 suture. After intubation, the mouse was placed on 2--2.5% isoflurane ventilation via the flexiVent (SCIREQ, Montreal, QC, Canada). A pulse oximeter (Kent Scientific Physiosuite) was placed on a foot or thigh to obtain heart rate (HR) information. Relevant equipment is listed in [Table 2](#table2-2045894020912937){ref-type="table"}. Table 2.Major equipment.RC2 rodent circuit controllerVetequip Inc.1452 N Vasco Rd. \#303Livermore, CA 94551922100TC-1000 temperature controllerCWE Inc.08-13000ADV500 advantage PV systemTransonic34 Dutch Mill RoadIthaca, NY 14850 3.5 mm PV catheterFTH-1212B-3518 4.0 mm PV catheterFTH-1212B-4018RA 834 data acquisition systemiWorx62 Littleworth RoadDover, NH 03820IX-RA-834 Labscribe 4 softwareflexiVentScireq6600 St-Urbain, Suite 300Montreal, QC H2S 3G8 CanadaMicrovent 1Hallowell EMC239 West StreetPittsfield, MA 01201Discontinued

Once the mouse was deeply anesthetized (as measured by failure of the toe pinch reflex and stable HR), 0.8--1.2 mg/kg of pancuronium was administered via intraperitoneal (i.p.) injection in order to prevent spontaneous respirations during the flexiVent analysis, which can interfere with data collection. Published studies indicated that pancuronium did not have significant effects on cardiovascular hemodynamics in porcine, rat, and humans with the exception of possible increases in HR.^[@bibr38-2045894020912937],[@bibr39-2045894020912937]^ Pancuronium has been used in concert with echocardiography to determine right ventricular structure in normal and hypoxic mice.^[@bibr40-2045894020912937]^ Alterations in HR may be used to monitor hemodynamic alterations due to anesthesia.^[@bibr41-2045894020912937]^

Procedure 1: Airway physiology measurements {#sec5-2045894020912937}
-------------------------------------------

Respiratory function was measured using the flexiVent FX equipped with a module 2 (SCIREQ, Scientific Respiratory Equipment Inc., Montreal, Canada). The system artificially ventilated the animal with short (1--8 s) pressure--volume measurement maneuvers, called perturbations, and measured the resulting expiratory pressure and volume changes as a function of time against a physiological positive end expiratory pressure of 2.5--5 cmH~2~O. Mathematical modeling was then applied to the signals generated from the perturbations resulting in the assessment of respiratory mechanics (flexiVent FX User Manual, SCIREQ). The following measures of respiratory mechanics were calculated from the flexiVent: inspiratory capacity (IC), total resistance (R), elastance (E), compliance (C), upper airway resistance, (Rus), respiratory system resistance (Rrs), Newtonian resistance (Rn), inertance (I), tissue damping (G), tissue elastance (H), and static compliance (Cst) (SCIREQ Method Note Understanding the flexiVent measures). The measures of most common interest in the literature include static compliance, a measure of the elastic properties of the respiratory system, and resistance of the respiratory system. Data were recorded continuously and analyzed offline. The airway physiology testing procedure took approximately 10 min per mouse, with the approximate surgery time of 5 min per animal.

Procedure 2: Cardiovascular hemodynamics -- Non-survival surgery {#sec6-2045894020912937}
----------------------------------------------------------------

Anesthesia was continued as one episode from the flexiVent analysis. At the conclusion of the airway physiology measurement, animals were immediately transferred to a Microvent 1 ventilator (Hallowell EMC, Pittsfield, MA) and isoflurane level maintained at 2.0--2.5% in 100% O~2~ or 21% O~2~/balance nitrogen for ventilated, open-chest studies. Peak breathing circuit pressure was maintained between 10 and 18 cmH~2~O, breaths per minute at 50--150, and the oxygen flow at 0.3--0.5 lpm. A rectal temperature probe was placed (CWE, TC-1000), and body temperature maintained at 37 ℃.

In an open-chest, solid-state catheterization procedure, ventricular function (right ventricle (RV) and left ventricle (LV)), pulmonary and systemic arterial pressures were measured with a 1.2 French Pressure-Volume Catheter (FTH-1212B-3518 or 4018, Transonic Systems Inc., Ithaca, NY) inserted into the heart directly through the wall via a diaphragmatic approach. The procedure was developed as a modification of Pacher et al. describing hemodynamic measurement of LV hemodynamics.^[@bibr42-2045894020912937]^ Right and left ventricular functions were assessed by recording cardiac output (CO), maximal ventricular pressure (Pmax), afterload (Ea), end diastolic pressure volume relationship (EDPVR; a measure of stiffness/diastolic dysfunction), end systolic pressure volume relationship (Ees; a measure of contractility), and ventricular--arterial coupling (Ea/Ees).

A transverse incision was made across the width of the abdomen below the xiphoid process and the diaphragm cut away from the ventral chest wall to expose the heart and lungs. A length of 3-0 suture was placed underneath the inferior vena cava just anterior to the diaphragm to be used as a snare for occlusions. The pericardium was resected, and a small hole was made at the base of the RV with a 30-gauge needle. The pressure--volume catheter was then inserted in the hole and advanced along the length of the chamber. Bleeding is usually minimal due to the small size of the hole and the larger catheter plugging it.

At the conclusion of initial catheter placement, isoflurane was adjusted to 1.5--2% and the animal was allowed to equilibrate for approximately 2 min. The decrease in anesthesia was optimized to obtain hemodynamic measurements that are as close to normal physiology as possible without compromising the surgical depth of anesthesia. Anesthesia was checked to ensure that the animal was still in a surgical plane and the catheter was moved to obtain optimal positioning within the ventricle. Steady state hemodynamics were collected with short pauses in ventilation (up to 10 s) to eliminate ventilator artifact from the pressure--volume recordings. Occlusions of the inferior vena cava were also performed by pulling the abdominal snare taught (up to 10 s as well). This was to assess the end systolic pressure--volume relationship. The catheter was removed from the RV and another small incision was in the apex of the LV and the catheter placed along the length of the LV for measurement of steady state and occlusion data in the LV. The catheter may have also been advanced into the aortic arch for the collection of systemic pressure. One final incision was made in the RV, just below the pulmonary artery (PA) and the catheter was inserted to collect pulmonary arterial pressures. The order of data collection was optimized based on the priority of the information being collected, RV, LV, then PA. The order may be changed depending on a laboratory\'s specific hypothesis.

Data were recorded continuously and analyzed offline. Once the catheters were removed, the isoflurane level was set to 5%, the inferior vena cava was re-exposed, a 23-gauge needle inserted and the animal was exsanguinated. Direct heart puncture was used alternatively for animal exsanguination. Total time from induction to exsanguination was approximately 30 min.

Anesthetic regimen and monitoring {#sec7-2045894020912937}
---------------------------------

Isoflurane was chosen due to its minimal cardiosuppressant effects, ease of monitoring, and control.^[@bibr42-2045894020912937],[@bibr43-2045894020912937]^ The following anesthesia guidelines were implemented: (1) Animals were initially anesthetized with 4--5% isoflurane in room air at 1 L/min for approximately 2 min using a box. (2) All surgical manipulations were performed between 2 and 4% isoflurane in a surgical plane of anesthesia using a nose cone. (3) Following surgical manipulations, mice were maintained at 2.0--2.5% isoflurane for airway physiology and 1.5--2.0% isoflurane for hemodynamic measurements using a nose cone. (4) After the mice were either connected to the flexiVent or to the ventilator used for hemodynamic measurements, the paralytic pancuronium was administered IP (0.8--1.2 mg/kg). The paralytic was used as it is critical that there is no spontaneous respiratory effort during airway physiology measurements. Mice were maintained at a minimum of 2% isoflurane, as Tsukamoto et al.^[@bibr44-2045894020912937]^ found that 100% of mice were in a surgical plane of anesthesia at 2% isoflurane.

Anesthesia monitoring included HR monitoring as well as monitoring for an acute rise in HR rise upon toe pinch. With hemodynamic measurements, both blood pressure and HR were recorded and monitored continuously via direct catheterization of the heart. Our goal was to maintain the HR at the same levels observed during the flexiVent procedure, generally between 450 and 650 beats/min, and/ or as typically seen during hemodynamics at 2% isoflurane, with no response to toe pinch. In the instance that HR decreases below 300 beats/min, the isoflurane concentration may be reduced to 1.5% in order to prevent anesthetic death. However, during the course of this study, no mouse HR dropped below 300 beats/min.

Histology {#sec8-2045894020912937}
---------

Lungs were flushed with phosphate buffered saline (PBS) through the RV. A 20-gauge needle was connected to the plastic catheter and syringe adapter was connected to the endotracheal tube already in place. The chest cavity was completely dissected to expose the lung and heart field. Lungs were inflated under constant pressure using 1% low-melt agarose prepared in PBS heated to 42 ℃. A manometer (Fisherbrand™ Traceable™ 06-664-18) kept in series to a 10 mL instillation syringe through a plastic tubing adapter (BD Intramedic™ 22-044083) was used to gauge infusion pressure. Two milliliters of warm agarose was added in the instillation syringe and lungs were slowly infused and a progressive and steady rise in the monometer to 25 cmH~2~O was observed. The lung block was then dissected, placed on ice to solidify for 5--10 minutes, and fixed overnight in 16% formalin.

To prepare inflated lungs for histology and to ensure randomization of tissue sections, lungs were embedded in a 4% agarose mold. Once the agarose solidified, it was placed in a random orientation into a cutting box (Exacto Machine & Tool, Indianapolis, IN). The lung was then cut on the transverse plane by sharp cryostat blades in 3 mm sections. The sections were placed into a histology cassette and processed for paraffin embedding. Tissue sections of 4 μm thick were cut. Standard H&E staining was performed.

Statistics {#sec9-2045894020912937}
----------

Data were analyzed by one-way ANOVA and T-test followed by Tukey\'s HSD post-hoc analysis. All analyses used JMP version 9.0.2. Data presented as ± standard error from the mean (±SEM). Significance was defined as p-value \<0.05\*, p-value \<0.01\*\*, or p-value \<0.001\*\*\*.

Results {#sec10-2045894020912937}
=======

Pressure--volume conductance catheter measurements of right ventricular systolic pressure (RVSP), left ventricular systolic pressure (LVSP), PA pressure, HR, and CO are commonly reported hemodynamic parameters for the study of vascular and cardiac dysfunction in murine models of chronic lung disease as well as pulmonary arterial hypertension. These endpoints are typically recorded using different mice. We sought to combine these analyses with measurements of airway physiology in order to present a comprehensive understanding of pulmonary tissue structure and function in a single animal, which may be applied to models of injury, disease, and tissue repair.

Age matched, 18.5-week-old male and female mice were randomized into three groups for comparison, Hdx, Flexi, or Flexi + Hdx. Mean body weight was significantly different between males and females; however, it was consistent throughout the groups ([Fig. 1](#fig1-2045894020912937){ref-type="fig"}a, [Table 2](#table2-2045894020912937){ref-type="table"}). Hematocrit and Fulton\'s index (RV/LV + S) was not significantly different between groups ([Fig. 1](#fig1-2045894020912937){ref-type="fig"}b and c, [Table 2](#table2-2045894020912937){ref-type="table"}). In humans, lung function can be measured using spirometry. However, this cannot be used in mice as it requires active participation from the subject or patient. Lung function was measured in the mouse using the flexiVent mouse ventilatory system. Measurement of airway physiology was performed alone or prior to the Hdx analysis. Values for typical endpoints were within the normal range and included total resistance (Rrs), system compliance (Crs), elastance (Ers), airway resistance (Rn), and static lung compliance (Cst) ([Fig. 1](#fig1-2045894020912937){ref-type="fig"}d--h, [Table 2](#table2-2045894020912937){ref-type="table"}). Fig. 1.Baseline comparisons between treatment groups. Measurements of lung and hemodynamic function in C57Bl6J mice (18.5 weeks old) that were anesthetized with inhaled isoflurane and i.p. pancuronium followed by measurement of hemodynamics only (Hdx), lung function only (Flexi), or the two combined (Flexi + Hdx). (a) Body weight, (b) hematocrit (HCT) and (c) RV/LV + S. flexiVent analysis of (d) total resistance (Rrs), (e) system compliance (Crs), (f) elastance (Ers), (g) airway resistance (Rn) and (h) static lung compliance (Cst). Data presented as mean (±SEM). The mean is indicated by +. n = 7--9 mice/group.

Measurement of cardiovascular physiology was performed alone or following the flexiVent analysis, as one continuous event. Pressure--volume loops (P--V loops) were collected in the RV, followed by the LV and lastly the catheter was inserted into the PA, via the RV. The events may be reordered depending on the focus of the study. The RVSP is typically analyzed first when the major interest is remodeling of the pulmonary vasculature. A second penetration of the RV is necessary to reangle the catheter and reach the PA, thus either the LV or PA may follow. Values for typical endpoints fell within a normal range and did not differ between the Hdx compared to the Flexi + Hdx groups. Common endpoints included RVSP, LVSP, PA pressure, CO, HR, and systemic pressure ([Fig. 2](#fig2-2045894020912937){ref-type="fig"}a--f, [Table 2](#table2-2045894020912937){ref-type="table"}). P--V loops were also not significantly different between these two groups ([Fig. 2](#fig2-2045894020912937){ref-type="fig"}g and h). Fig. 2.Hemodynamic outcomes are not affected by flexiVent analysis. Hemodynamics (Hdx) measurement alone or following flexiVent analysis in C57Bl6J mice (18.5 weeks old) anesthetized with inhaled isoflurane and i.p. pancuronium. (a) A pressure transducer was placed in the right ventricle to measure RVSP or the (b) left ventricle to measure LVSP followed by (c) reinsertion into the RV and PA to measure PA pressure. (d) Cardiac output (CO), (e) heart rate, and (f) systemic pressure. The Hdx fell within a normal range and values were not significantly changed following flexivent analysis. Data presented as the mean (±SEM). The mean is indicated by +. n = 7--9 mice/group.

Since we implemented these methods on healthy WT mice, to validate their implementation in other rodent models, we performed flexivent + hemodynamic measurements on aged transgenic mice (∼15 months of age). WT mice were compared to mice that had Wnt activated (BOE) specifically in mesenchymal vascular progenitor cells (MVPC).^[@bibr37-2045894020912937]^ We have previously described that MVPC specific Wnt activation results in lung microvascular dysfunction and remodeling. One year following tamoxifen induction, mice were analyzed. Body weight and hematocrit was lower in the BOE group relative to WT, while Fulton\'s index was similar ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}a--c). Measurement of airway physiology was performed combined with Hdx analysis ([Table 3](#table3-2045894020912937){ref-type="table"}; [Fig. 3](#fig3-2045894020912937){ref-type="fig"}d--h). Total airflow resistance (Rrs) in old WT mice was similar to young WT mice ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}d), whereas their elastance (Ers) was decreased ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}f). BOE group had significant changes compared to WT mice in both airflow resistance, which was increased ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}g), and in lung compliance (Crs), which was reduced, with corresponding increases in elastance ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}d and e). The systemic compliance (Cst) was also significantly decreased in the BOE lungs when compared to WT. Taken together these data suggest that aging increased lung stiffness and this effect was worse in the BOE group. Fig. 3.Aged mice demonstrate increased lung stiffness in the absence of hypertension. flexiVent analsysis with hemodynamics (Hdx) measurement in WT or BOE mice one year following induction. (a) Body weight, (b) hematocrit (HCT)m and (c) RV/LV+S. flexiVent analysis of (d) total resistance (Rrs), (e) system compliance (Crs), (f) elastance (Ers), (g) airway resistance (Rn), and (h) static lung compliance (Cst). (i) A pressure transducer was placed in the right ventricle to measure RVSP or the (j) left ventricle to measure LVSP followed by reinsertion into the RV to measure (k) Cardiac output (CO), (l) heart rate, and (m) systemic pressure. Data presented as mean (±SEM). The mean is indicated by +. n = 5--10 mice/group. Table 3.Pulmonary physiology measures per aged mouse.GroupSexWeight (g)HCTRV/ LV + SRVSP (mmHg)LVSP (mmHg)CO (mL/ min)HR (beats/min)Mean systemic pressure (mmHg)PA pressure (mmHg)Rrs (cmH~2~O.s/ mL)Crs (mL/ cmH~2~O)Ers (cmH~2~O/ mL)Rn (cmH~2~O.s/ mL)Cst (mL/ cmH~2~O)WTF24.9430.39228.4946.58315.9951632.9516.240.5330.06016.7900.3110.099WTF24.2490.30123.5674.62312.1660535.970.4510.05618.0270.2140.093WTF26.6520.31422.7249.35111.4948448.1719.541.0400.08112.3470.7480.124WTF25.2450.34626.0662.259.1561251.2713.990.4380.06216.1960.2660.101WTF23.6340.3630.3940.05617.8660.1610.088WTM30.3460.29326.8558.3419.7954634.570.4300.06116.4330.2250.103WTM31.3430.29431.6979.81412.8950356.9723.950.3520.07613.1100.1680.123WTM31.2450.34927.9766.38410.9257446.5423.620.4440.05518.0930.2020.101WTM31.9430.43527.7863.13712.4551949.1117.030.3640.07712.9820.2000.116WTM32410.28828.6551.20813.0359433.720.3910.06415.7460.2200.095BOEM23.2400.29427.5910.745100.5200.05219.1730.2410.080BOEF19.6300.36628.54277.7961252164.710.5190.05518.1550.2910.082BOEF20.3430.2925.17773.0028.8659951.4613.160.4670.05318.8880.2070.081BOEF23.5310.37327.54756.33713.1662042.2414.870.5500.05418.4440.3150.081BOEF25.1260.28333.53775.52911.4646053.3816.240.7630.05119.7680.4860.075

As with the young mice, measurement of cardiovascular physiology was performed following the flexiVent analysis. Values for typical endpoints fell within a normal range and did not differ significantly between the WT and BOE groups ([Fig. 3](#fig3-2045894020912937){ref-type="fig"}i--m, [Table 3](#table3-2045894020912937){ref-type="table"}). No indication of hypertension, pulmonary or systemic, was detected. The HR and CO of the WT aged mice fell within the range of the young mice (between 550 and 650 beats/min; [Figs. 3](#fig3-2045894020912937){ref-type="fig"}k and l and [2](#fig2-2045894020912937){ref-type="fig"}d and e), demonstrating there was no significant impact of pancuronium on cardiovascular hemodynamics.^[@bibr41-2045894020912937]^

To determine the morphological aspects underlying the changes in lung function described above, as well as any impact of methodology in lung structure or inflammation, images of H&E stained lung sections were taken on a Nikon Eclipse 80i microscope using NIS Elements AR software ([Fig. 4](#fig4-2045894020912937){ref-type="fig"}). As expected, there was no change in tissue morphology in groups that underwent hemodynamics or Flexi groups, when compared to the combination of Flexi + Hdx, regardless of age. Inflammation was only noted in BOE mice that had evidence of perivascular inflammation ([Fig. 4](#fig4-2045894020912937){ref-type="fig"}a--f). There was no effect of measurement of both hemodynamics and flexivent on lung inflammation. Taken together these data illustrate that both airway and cardiovascular physiology measurements may be recorded sequentially using mouse models without any impact on tissue structure and inflammation. Fig. 4.Coupling flexivent and hemodynamics does not affect tissue morphology. Lungs were agarose inflated using constant pressure to obtain tissue for histological H&E or trichrome staining. Representative images were presented for young WT mice: (a) Hdx only, (b) flexiVent only, and (c) flexivent + Hdx or flexivent + Hdx for aged (d) WT and (e) and (f). BOE mice. Scale bars = 100 μM. n = 7--9 mice/group.

Discussion {#sec11-2045894020912937}
==========

To provide a comprehensive overview of pulmonary function, we combined analyses of airway physiology with cardiovascular hemodynamics in mice. The integration of the airway and cardiovascular function is necessary to understand underlying pathophysiology that characterizes loss of tissue function. We found that the use of pancuronium as a neuromuscular blocking agent followed by continuous inhaled isoflourane, yielded reproducible airway function and cardiovascular hemodynamic results in naïve C57Bl6 mice. Taken together, these data documented that there was no significant difference between the Hdx group relative to group analyzed by both the flexiVent and Hdx procedures, in terms of physiology and histologic endpoints.

Because we did not find a difference in the respiratory or cardiovascular measures between the different groups, going forward, we have validated that it is possible to add pulmonary function testing with the flexiVent before hemodynamics. This increases the data that we can collect from each animal and reduces the number of animals required for answering our experimental questions, since we can perform both pulmonary and cardiac function tests on the same animal. It is also of great value to be able to have all of these data on a single animal so that cardiovascular function can be related to pulmonary function, since these two systems are so closely linked. Dayeh et al. found that mice with induced PH via pulmonary artery ligation had both an increased RVSP associated with the PH, as assessed with echocardiography and direct measures using a high fidelity catheter placed in the RV or LV, and also had an increased respiratory compliance, assessed with flexiVent.^[@bibr45-2045894020912937]^ These values were assessed in the same mice. By collecting data on pulmonary function testing and Hdx measurements in the same animals, we can help correlate these findings with human pathophysiology, furthering the ability to test treatments in experimental mouse models.

Prior to completing this experiment, we performed a brief pilot experiment to optimize anesthesia for combining flexiVent with Hdx. We tested ketamine (K) (80--120 mg/kg)/xylazine (X) (10--15 mg/kg)/pancuronium (P) (0.8--1.2 mg/kg). Although this combination (K/X/P) achieved adequate anesthesia, it caused greater depression in hemodynamic measurements compared to isoflurane and pancuronium. In addition, K/X/P was more difficult to titrate in a swift and precise manner. Mice anesthetized with either K/X/P or isoflurane with pancuronium had no difference between flexiVent and Hdx measurements in mice that had Flexi, Hdx, or flexiVent/Hdx combined. In addition, we were able to adequately anesthetize mice with isoflurane, an anesthetic with negligible impact on Hdx endpoints, which also offers the advantage of precise titration. Therefore, we determined that isoflurane with pancuronium was a superior anesthetic protocol for this experiment.

With regard to right ventricular function analysis, the measure of load-independent RV contractility is generally calculated as the slope of the end-systolic pressure--volume relationship (end-systolic elastance, Ees).^[@bibr46-2045894020912937]^ The gold standard methodology for measuring Ees in rodents is by creating multiple pressure--volume loops at varying loads by completing occlusions, a method we employed here.^[@bibr47-2045894020912937]^ The resulting Ees calculated from occlusion is found as the slope of a line fit to the end-systolic pressure points from multiple loops (known as "multi-beat" method). Often, investigators approximate this method by the single-beat method, which can estimate Ees from the pressure waveform of a single beat. However, the automated fitting procedure in single beat estimates can fail for certain pressure waveform morphologies^[@bibr48-2045894020912937]^ and suffers from repeatability issues because there is no agreed-upon methodology for identifying the true iso-volumic region in a pressure waveform.^[@bibr49-2045894020912937],[@bibr50-2045894020912937]^ Thus, in our study we evaluated cardiac contractility by the multi-beat method, which is the "gold standard" approach. Although occlusions are an invasive procedure, there was no difference between animals that had been analyzed by the flexivent first, further demonstrating that utilizing the flexivent does not disturb cardiac function.

This study has validated the ability to perform both pulmonary function testing and Hdx testing on in same animal, without impacting the findings for either testing modality. This combined procedure may be used to both decrease the required number of study participants as well as increase the data points collected from each participant. A fundamental question that remains is how deregulated angiogenesis may hinder the physiologic function of the lung. Establishing these mechanisms would provide key new insights into the pathogeneis of CLD and Group 3 PH and make it essential to examine the vascular and epithelial niches in murine models of emphysema and fibrosis. The ultimate goal of combining vascular and airway analyses into a single mouse is to identify a parallel time course of progression of injury to disease in both the cardiovascular and airway niches. Therefore, the next step is to validate this technology in well established murine models of chronic lung disease.
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